ResearcherOsaka International Cancer InstituteNo recent work listed
Kazuhiro Katayama
Matched on ORCID iD 0000-0003-4232-7661; OpenAlex author ID A5050674818. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2012: 2 papers · 2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper
Papers 8
- Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barc… Co-author DOI 10.1371/journal.pone.0192611↗
- [The progress of chemotherapy for advanced pancreatic cancer]. First author DOI 10.11405/nisshoshi.112.2119↗
- A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile. Last author DOI 10.1371/journal.pone.0132223↗
- Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. Last author DOI 10.1159/000364819↗
- Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. Last author DOI 10.1007/s00535-012-0693-x↗
- Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based on post-marketing surveillance in Japan. First author DOI 10.1093/jjco/hys211↗
- Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including g… Co-author DOI 10.1007/s00534-012-0514-x↗
- Diagnostic clues and subsequent examinations that detected small pancreatic cancer. Co-author DOI 10.5754/hge12213↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuya Ioka · 5 shared papers, 2012–2015 · strength 0.20
- Paper [The progress of chemotherapy for advanced pancreatic cancer]. DOI 10.11405/nisshoshi.112.2119↗
- Paper Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based o… DOI 10.1093/jjco/hys211↗
- Paper Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. DOI 10.1159/000364819↗
- Reiko Ashida · 3 shared papers, 2013–2015 · strength 0.14
- Paper [The progress of chemotherapy for advanced pancreatic cancer]. DOI 10.11405/nisshoshi.112.2119↗
- Paper Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based o… DOI 10.1093/jjco/hys211↗
- Paper Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. DOI 10.1159/000364819↗
- Ryoji Takada · 2 shared papers, 2014–2018 · strength 0.14
- Paper Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation seque… DOI 10.1371/journal.pone.0192611↗
- Paper Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. DOI 10.1159/000364819↗
- Kazuyoshi Ohkawa · 2 shared papers, 2013–2018 · strength 0.13
- Paper Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation seque… DOI 10.1371/journal.pone.0192611↗
- Paper Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. DOI 10.1007/s00535-012-0693-x↗
- Nobuyasu Fukutake · 3 shared papers, 2013–2015 · strength 0.12
- Paper A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile. DOI 10.1371/journal.pone.0132223↗
- Paper Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. DOI 10.1159/000364819↗
- Paper Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. DOI 10.1007/s00535-012-0693-x↗
- Sachiko Tanaka · 3 shared papers, 2012–2013 · strength 0.10
- Paper Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based o… DOI 10.1093/jjco/hys211↗
- Paper Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. DOI 10.1007/s00535-012-0693-x↗
- Paper Diagnostic clues and subsequent examinations that detected small pancreatic cancer. DOI 10.5754/hge12213↗
- Kikuya Kato · 1 shared paper, 2018 · strength 0.10
- Yoji Kukita · 1 shared paper, 2018 · strength 0.10
- Hidenori Takahashi · 2 shared papers, 2012–2015 · strength 0.09
- Yasuhiko Tomita · 2 shared papers, 2012–2014 · strength 0.07
- Paper Duodenal Hemorrhage from Pancreatic Cancer Infiltration Controlled through Combination Therapy with Gemcitabine and S-1. DOI 10.1159/000364819↗
- Paper Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated wit… DOI 10.1007/s00534-012-0514-x↗
- Osamu Ishikawa · 2 shared papers, 2012–2013 · strength 0.06
- Paper Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. DOI 10.1007/s00535-012-0693-x↗
- Paper Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated wit… DOI 10.1007/s00534-012-0514-x↗
- Natsuko Kawada · 2 shared papers, 2012 · strength 0.06
- Teruki Teshima · 1 shared paper, 2015 · strength 0.06
- Masato Sakon · 1 shared paper, 2015 · strength 0.06
- Kazuaki Shimada · 1 shared paper, 2015 · strength 0.04
- Makoto Ueno · 1 shared paper, 2015 · strength 0.04
- Nobuyoshi Hiraoka · 1 shared paper, 2015 · strength 0.04
- Hisashi Taniai · 1 shared paper, 2013 · strength 0.04
- Takuo Yamai · 1 shared paper, 2014 · strength 0.04
- Kenji Ikezawa · 1 shared paper, 2013 · strength 0.03
- Arata Sakai · 1 shared paper, 2013 · strength 0.03
- Satoaki Nakamura · 1 shared paper, 2012 · strength 0.03
- Hiroaki Ohigashi · 1 shared paper, 2012 · strength 0.03
- Osamu Ishikawa · 1 shared paper, 2012 · strength 0.03
- Shigenori Nagata · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.